Zili Chen
Guiyang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Ubiquitin-specific protease 1 acts as an oncogene and promotes lenvatinib efficacy in hepatocellular carcinoma by stabilizing c-kit.
Journal: Annals of hepatology
Published: November 08, 2021
An aberrant DNA methylation signature for predicting hepatocellular carcinoma.
Journal: Annals of translational medicine
Published: January 25, 2021
microRNA-139-3p Inhibits Malignant Behaviors of Laryngeal Cancer Cells via the KDM5B/SOX2 Axis and the Wnt/β-Catenin Pathway.
Journal: Cancer management and research
Published: June 22, 2020
Long Noncoding RNA RP5-833A20.1 Suppresses Tumorigenesis In Hepatocellular Carcinoma Through Akt/ERK Pathway By Targeting miR-18a-5p.
Journal: OncoTargets and therapy
Published: June 17, 2019
MiR-1297 suppresses pancreatic cancer cell proliferation and metastasis by targeting MTDH.
Journal: Molecular and cellular probes
Published: January 27, 2018
LncRNA CRNDE promotes hepatic carcinoma cell proliferation, migration and invasion by suppressing miR-384.
Journal: American journal of cancer research
Published: May 17, 2016
[Retracted] MicroRNA‑526a targets p21‑activated kinase 7 to inhibit tumorigenesis in hepatocellular carcinoma.
Journal: Molecular medicine reports
Published: January 27, 2016
MicroRNA-526a targets p21-activated kinase 7 to inhibit tumorigenesis in hepatocellular carcinoma.
Journal: Molecular medicine reports
Published: January 27, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026